<DOC>
	<DOCNO>NCT00790088</DOCNO>
	<brief_summary>The aim project document international routine practice sensor usage patient treat sensor-augmented pump therapy ass variable ( e.g . training patient , frequency sensor usage etc ) associate improvement clinical outcome ( ) start sensor use end follow-up period .</brief_summary>
	<brief_title>INTERPRET - International Report Routine Practice Sensor-enabled Pump Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patient ( and/or legal representative ) sign Patient Informed Consent ( PIC ) Patient diagnose Type 1 DM insulin infusion pump therapy ( without additional insulin injection ) least 6 month prior signature PIC The treat physician decide independently study prescribe nonblinded continuous glucose monitor part patient 's pump therapy least 10 % study time ( estimate day per month ) Participation clinical trial currently and/or last 3 month prior signature inform consent Patient preliminary experience nonblinded continuous glucose monitoring prior signature inform consent ( na√Øve nonblinded continuous glucose monitoring ) For child : reliable contact person</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>continuous glucose monitoring</keyword>
	<keyword>sensor-augmented pump therapy</keyword>
</DOC>